USD 215.14
(-1.75%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 248.24 Million | 37.15 Million | 65.68 Million | 148.04 Million | 149.56 Million | 115.7 Million |
Net Income | 33.13 Million | -424.86 Million | -117.2 Million | -216.52 Million | -86.41 Million | -37.12 Million |
Depreciation & Amortization | 26.44 Million | 22.85 Million | 18.88 Million | 17.18 Million | 16.71 Million | 11.5 Million |
Deferred income taxes | -8.78 Million | -57.86 Million | 54.45 Million | -3.25 Million | 935 Thousand | -959 Thousand |
Stock-based compensation | 224.62 Million | 236.83 Million | 221.39 Million | 147.31 Million | 109.33 Million | 72.33 Million |
Change in working capital | -33.39 Million | 48.38 Million | 41.35 Million | 168.89 Million | 88.4 Million | 60.04 Million |
Other non-cash items | 6.21 Million | 211.8 Million | -153.18 Million | 34.42 Million | 20.59 Million | 9.9 Million |
Investing Cash Flow | 566.71 Million | -54.65 Million | 376.86 Million | -800.23 Million | -244.01 Million | -287.58 Million |
Investments in PPE | -66.16 Million | -70.66 Million | -37.7 Million | -18.85 Million | -22.06 Million | -14.07 Million |
Acquisitions | 111 Thousand | 51.59 Million | -23.95 Million | -6.62 Million | -3.86 Million | -392 Thousand |
Investment purchases | -312.25 Million | -970.51 Million | -605.68 Million | -1.34 Billion | -702.73 Million | -498.19 Million |
Sales/Maturities of investments | 945.12 Million | 934.92 Million | 1.04 Billion | 572.65 Million | 481.68 Million | 225.17 Million |
Other Investing Activities | -111 Thousand | -580 Thousand | 455.36 Million | -5.64 Million | 2.97 Million | -108 Thousand |
Financing Cash Flow | -450.02 Million | -189.16 Million | -160.05 Million | 552.93 Million | 31.49 Million | 417.7 Million |
Debt repayment | -362.66 Million | -45.05 Million | -26.68 Million | -575 Million | - | -12.6 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -127.01 Million | -231.87 Million | -200 Million | - | - | 32.89 Million |
Common Stock Issuance | 39.66 Million | 42.71 Million | 39.94 Million | -6.35 Million | 31.49 Million | 32.89 Million |
Other Financing Activities | 39.66 Million | 42.71 Million | 39.94 Million | -22.06 Million | 31.49 Million | 397.41 Million |
Accounts receivables | -15.3 Million | -11.71 Million | -6.25 Million | -6.45 Million | -3.45 Million | -2.12 Million |
Accounts payables | -52.45 Million | -18.51 Million | 26.59 Million | 41.96 Million | -7.56 Million | 10.93 Million |
Inventory | - | - | -61.35 Million | 20.11 Million | 28.02 Million | -3.44 Million |
Other working capital | 34.36 Million | 78.61 Million | 82.36 Million | 113.27 Million | 71.39 Million | 54.68 Million |
Cash at beginning of period | 258.35 Million | 451.35 Million | 168.85 Million | 268.1 Million | 331.05 Million | 85.23 Million |
Cash at end of period | 611.74 Million | 244.68 Million | 451.35 Million | 168.85 Million | 268.1 Million | 331.05 Million |
Capital Expenditure | -66.16 Million | -70.66 Million | -37.7 Million | -18.85 Million | -22.06 Million | -14.07 Million |
Effect of forex changes on cash | -11.54 Million | - | - | - | - | - |
Net cash flow / Change in cash | 353.39 Million | -206.66 Million | 282.49 Million | -99.24 Million | -62.95 Million | 245.82 Million |
Free Cash Flow | 182.08 Million | -33.51 Million | 27.98 Million | 129.19 Million | 127.49 Million | 101.63 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 39.51 Million | 24 Million | 2.95 Million | 33.13 Million | 6.97 Million | 33.57 Million |
Depreciation & Amortization | 7.89 Million | 7.92 Million | 8.21 Million | 26.44 Million | 5.83 Million | 5.98 Million |
Deferred income taxes | 5.01 Million | -5.01 Million | -1.93 Million | -8.78 Million | 3.71 Million | -6.31 Million |
Stock-based compensation | 59.88 Million | 58.14 Million | 58.19 Million | 224.62 Million | 58.24 Million | 53.66 Million |
Change in working capital | 1.84 Million | 29.87 Million | 24.66 Million | -33.39 Million | -15.22 Million | -36.1 Million |
Other non-cash items | 93.52 Million | 73.89 Million | -5.43 Million | 6.21 Million | 4.59 Million | -3.04 Million |
Investing Cash Flow | -131.29 Million | 9.09 Million | 67.95 Million | 566.71 Million | -45.31 Million | 480.85 Million |
Investments in PPE | -7.06 Million | -8.12 Million | -9.43 Million | -66.16 Million | -19.37 Million | -15.75 Million |
Acquisitions | - | - | -1.00 | 111 Thousand | 686 Thousand | -576 Thousand |
Investment purchases | -162.34 Million | -58.55 Million | -98.06 Million | -312.25 Million | -138.88 Million | -4.48 Million |
Sales/Maturities of investments | 37.57 Million | 75.77 Million | 175.45 Million | 945.12 Million | 112.94 Million | 501.19 Million |
Other Investing Activities | 545.49 Thousand | 16.8 Million | -1.00 | -111 Thousand | -686 Thousand | 465 Thousand |
Financing Cash Flow | -219.76 Million | -218.67 Million | -54.37 Million | -450.02 Million | 17.93 Million | -411.49 Million |
Debt repayment | - | - | -1.29 Million | -362.66 Million | -39.38 Million | -362.66 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -221.17 Million | -241.3 Million | -56.39 Million | -127.01 Million | 1.05 Million | -50 Million |
Common Stock Issuance | 1.41 Million | 22.62 Million | 728.35 Thousand | 39.66 Million | 17.04 Million | 841.25 Thousand |
Other Financing Activities | 1.61 Million | 22.62 Million | 3.87 Million | 39.66 Million | 117.97 Million | 1.17 Million |
Accounts receivables | 477.8 Thousand | 1.11 Million | -2.65 Million | -15.3 Million | -1.33 Million | -708 Thousand |
Accounts payables | -14.36 Million | -2.12 Million | 14.83 Million | -52.45 Million | -14.6 Million | -11.3 Million |
Inventory | - | - | -1.00 | - | 327 Thousand | -36.13 Million |
Other working capital | 20.9 Million | 30.88 Million | 12.48 Million | 34.36 Million | 387 Thousand | 12.04 Million |
Cash at beginning of period | 514.62 Million | 611.74 Million | 507.68 Million | 258.35 Million | 468.03 Million | 350.91 Million |
Cash at end of period | 277.36 Million | 514.62 Million | 611.74 Million | 611.74 Million | 504.79 Million | 468.03 Million |
Capital Expenditure | -7.06 Million | -8.12 Million | -9.43 Million | -66.16 Million | -19.37 Million | -15.75 Million |
Effect of forex changes on cash | -1.59 Million | -553 Thousand | 3.83 Million | -11.54 Million | - | - |
Net cash flow / Change in cash | -237.26 Million | -97.11 Million | 104.06 Million | 353.39 Million | 36.75 Million | 117.12 Million |
Free Cash Flow | 111.04 Million | 105.71 Million | 77.2 Million | 182.08 Million | 44.76 Million | 32.01 Million |
BUD
AARTIDRUGS
IRRA
GATEU
PH
NKT